Revvity Inc (STU:PKN)
€ 112.65 4.2 (3.87%) Market Cap: 13.59 Bil Enterprise Value: 15.56 Bil PE Ratio: 57.01 PB Ratio: 1.82 GF Score: 80/100

Q2 2021 PerkinElmer Inc Earnings Call Transcript

Jul 26, 2021 / 12:00PM GMT
Release Date Price: €132.7 (-3.49%)
Operator

Good day and thanks for standing by. Welcome to the 2021 Second Quarter Earnings Conference Call. (Operator Instructions)

Now I would like to turn the call over to our first presenter for today, Mr. Stephen Willoughby, Vice President of Investor Relations. Sir, please go ahead.

Steve Willoughby

Thank you, Henry.

Good morning, everyone, and welcome to PerkinElmer's Second Quarter 2021 Earnings Conference Call. We are speaking to you this morning from San Diego and have quite a bit to get to given today's exciting announcement, in addition to the earlier-than-expected release of our second quarter results.

On the call with me today are Prahlad Singh, our President and Chief Executive Officer; Jamey Mock, our Senior Vice President and Chief Financial Officer; and Gene Lay, Founder and Chief Executive Officer of BioLegend. If you have not yet received a copy of our earnings press release or slide presentation or BioLegend-related slide presentation or press release, you may find copies of them on the Investors section of our website at

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot